Discontinued — last reported Q4 '20
UnitedHealth Group Available-for-Sale Debt Securities - Amortized Cost increased by 21.0% to $6.70B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 33.2%, from $5.03B to $6.70B. Over 4 years (FY 2020 to FY 2024), Available-for-Sale Debt Securities - Amortized Cost shows an upward trend with a 6.9% CAGR.
Changes reflect shifts in the company's investment portfolio size and strategy regarding liquid debt holdings.
This metric reflects the initial cost of debt securities classified as available-for-sale, adjusted for amortization of...
Standard for any company with a significant cash and investment portfolio.
afs_debt_securities_amortized_cost| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.24B | $4.28B | $39.67B | $4.26B | $4.61B | $5.09B | $45.93B | $5.65B | $5.18B | $5.22B | $47.45B | $4.91B | $4.74B | $5.03B | $49.82B | $5.29B | $5.54B | $6.70B |
| QoQ Change | — | +0.9% | +826.8% | -89.3% | +8.2% | +10.5% | +802.6% | -87.7% | -8.3% | +0.8% | +809.2% | -89.7% | -3.4% | +6.1% | +890.0% | -89.4% | +4.7% | +21.0% |
| YoY Change | — | — | — | — | +8.6% | +18.9% | +15.8% | +32.7% | +12.5% | +2.6% | +3.3% | -13.1% | -8.5% | -3.6% | +5.0% | +7.8% | +16.8% | +33.2% |
We use cookies for analytics. See our Privacy and Cookie Policy.